Background: Renal hypoxia is an aggravating factor for tubulointerstitial damage, which is strongly associated with renal prognosis in diabetic kidney disease (DKD). Therefore, urinary markers that can detect renal hypoxia are useful for monitoring DKD. Objective: To determine the correlation between urinary liver-type fatty acid-binding protein (L-FABP) and renal hypoxia using a novel animal model of type 2 diabetes. Methods: Male spontaneously diabetic Torii (SDT) fatty rats (n = 6) were used as an animal model of type 2 diabetes. Age-and sexmatched Sprague-Dawley (SD) rats (n = 8) were used as controls. Body weight, systolic blood pressure, and blood glucose levels were measured at 8, 12, 16, and 24 weeks of age. Urine samples and serum and kidney tissues were collected at 24 weeks of age. Microvascular blood flow index (BFI) was measured using diffuse correlation spectroscopy before sampling both the serum and kidneys for the evaluation of renal microcirculation at the corticomedullary junction. Results: Obesity, hyperglycemia, and hypertension were observed in the SDT fatty rats. Focal glomerular sclerosis, moderate interstitial inflammation, and fibrosis were significantly more frequent in SDT fatty rats than in SD rats. While the frequency of peritubular endothelial cells and phosphoendothelial nitric oxide synthase levels were similar in both types of rats, the degree of renal hypoxia-inducible factor-1α (HIF-1α) expression was significantly higher (and with no change in renal vascular endothelial growth factor expression levels) in the SDT fatty rats. Urinary L-FABP levels were significantly higher and renal microvascular BFI was significantly lower in the SDT fatty rats than in the SD rats. Urinary L-FABP levels exhibited a significant positive correlation with renal HIF-1α expression and a significant negative correlation with renal microvascular BFI. Conclusions: Urinary L-FABP levels reflect the degree of renal hypoxia in DKD in a type 2 diabetic animal model. Urinary L-FABP may thus prove useful as a renal hypoxia marker for monitoring DKD in patients with type 2 diabetes in clinical practice. The midsection of each excised kidney was dissected in the minor axial direction. The 2 pieces were fixed in 10% buffered formalin or methyl Carnoy's solution (60% methanol, 30% chloroform, and 10% glacial acetic acid) and embedded in paraffin. Serial sections (3 μm thick) were prepared for renal histological assessment including periodic acid-Schiff (PAS) staining and immunohistochemistry (IHC).
Introduction
Despite the development of numerous therapeutics for diabetes, diabetic kidney disease (DKD) remains a major cause of end-stage renal failure globally [1, 2] and is associated with an increase in medical care expenses [3] . Owing to the limited number of therapeutic strategies presently available, monitoring for DKD is critical for prompt multidisciplinary management, and novel biomarkers that can provide detailed kidney status of patients with DKD are sorely required.
Tubulointerstitial damage is strongly associated with renal prognosis in DKD [4] [5] [6] , and renal hypoxia is an aggravating factor for the progression of this damage [7] [8] [9] . Tubular biomarkers that reflect the degree of renal hypoxia as well as tubulointerstitial damage would therefore be useful for monitoring DKD.
Urinary liver-type fatty acid-binding protein (L-FABP) is a tubular marker that accurately reflects the severity of tubulointerstitial damage in chronic kidney disease including DKD [10] [11] [12] and acute kidney disease [13, 14] . L-FABP has been promulgated as a tubular biomarker by the Ministry of Health, Labour and Welfare in Japan [15] . An increase in urinary L-FABP has been reported to be an independent risk factor for DKD progression in type 1 and 2 diabetes [16] [17] [18] . Although urinary L-FABP levels were reported to be associated with renal microcirculation in donors during surgery for renal transplantation [19] , no correlation with renal hypoxia in DKD has been elucidated to date. Therefore, we assessed the correlation between urinary L-FABP levels and renal hypoxia in a rat model of type 2 diabetes using spontaneously diabetic Torii (SDT) fatty (SDT.Cg-Lepr fa /JttJcl) rats, a novel model that mimics the human pathophysiology of type 2 diabetes that is accompanied by obesity, hyperlipidemia, and hypertension [20] . The renal hypoxia was evaluated by renal hypoxia-inducible factor-1α (HIF-1α) expression, and the microvascular blood flow index (BFI) was measured using diffuse correlation spectroscopy (DCS).
Materials and Methods

Animals
All animal studies were conducted in accordance with the St. Marianna University School of Medicine Institutional Guide for Animal Experiments and the Guide for the Care and Use of Laboratory Animals. Male SDT fatty rats derived from a Sprague-Dawley (SD) colony were used as a model of type 2 diabetes. Four-week-old male SDT fatty rats (n = 7) and age-matched control SD rats (n = 8) were purchased from CLEA Japan (Tokyo, Japan) and allowed free access to laboratory chow (CRF-2; Charles River Laboratories Japan, Yokohama, Japan) and water. One STD fatty rat died at 23 weeks of age, but the remaining 6 underwent extensive analyses. To confirm the diabetic status, blood glucose levels were measured 4 h after the removal of the chow with the Free Style Freedom Lite (Niporo, Osaka, Japan) in blood collected from the tail vein.
For all experiments, 24-week-old rats were individually housed overnight in metabolic cages with free access to tap water. Urine was collected for the measurement of urinary markers. Additionally, under inhalation anesthesia using 2% isoflurane, serum samples and kidney tissues were collected. The extracted kidneys were weighed, sectioned, and stored either at −80 ° C or in liquid nitrogen for downstream analyses.
Body Weight and Blood Pressure Measurement
Body weight and systolic blood pressure (SBP) were measured every 4 weeks from 8 to 24 weeks of age. SBP was measured using a tail-cuff apparatus (Softron BP-98A; Softron, Tokyo, Japan), and averages of 3 SBP measurements per animal per time point were recorded [11] .
Determination of Microvascular BFI Using DCS
Microvascular BFI was measured using DCS, which detects tissue blood flow velocity using intensity fluctuations of a reflected near-infrared light due to the movement of red blood cells in the microvasculature [21] [22] [23] . The measurements were performed immediately before sampling both the serum and kidneys at 24 weeks of age. Briefly, under inhalation anesthesia using 2% isoflurane, the rats underwent left abdominal laparotomy. Photonemitter and detector probes were placed at 4-mm intervals directly on the left renal surface to detect the emitted near-infrared light from the renal parenchyma for 2 min. The DCS system enables BFI measurements of the region in approximately half the depth (2 mm) of the distance between the 2 probes below the renal surface [24] ; this allows the detection of microvascular blood flow in the corticomedullary area. The near-infrared light sent from the photon-emitter probe is irradiated from the renal surface to the blood flowing in the peritubular capillaries of the renal cortex. The light is diffused by the red blood cells, and this reflected light is recorded by the detector probe. Microvascular BFI is defined as the blood velocity calculated from an autocorrelation-related change in the reflected light [21] and we used it to determine the degree of change in microvascular blood flow.
Serum and Urinary Biochemistry
Serum and urine creatinine levels were measured using a Quantichrom TM creatinine assay kit (BioAssay Systems, Hayward, CA, USA). Serum cystatin C levels were measured using a rat cystatin C enzyme-linked immunosorbent assay (ELISA) kit (BioVendor, Brno, Czech Republic). Serum urea nitrogen levels were measured via urease-LED-ultraviolet absorption spectrophotometry, serum total cholesterol levels using the cholesterol oxidase enzymatic method, and serum triglyceride levels using an enzymatic method provided by the SRL clinical laboratory testing services (Tokyo, Japan). Urinary glucose levels were determined semiquantitatively using urinary dipsticks (WAKO Pure Chemical Industries, Osaka, Japan). Grading for urinary glucose was as follows: 0, negative; 1+, > 100 mg/dL; 2+, > 250 mg/ dL; 3+, > 500 mg/dL; and 4+, > 2,000 mg/dL. Levels of urinary L-FABP and albumin were measured using rat L-FABP (CMIC, Tokyo, Japan) and rat albumin (Fujifilm WAKO Shibayagi, Gunma, Japan) ELISA kits, respectively. They were reported as ratios relative to the urinary creatinine levels.
IHC Analyses of the Renal Tissues
Target antigens in the preprocessed sections were stained using the indirect immunoperoxidase method, as described previously [11] . Briefly, the formalin-fixed/paraffinembedded tissue specimens were used to stain for myofibroblasts and tubular cells exhibiting the epithelial-mesenchymal transition by using a mouse monoclonal antibody specific for α-smooth muscle actin (α-SMA, 1: 800; Sigma-Aldrich, St. Louis, MO, USA). The tissue specimens fixed in methyl Carnoy's solution were assessed immunohistochemically for macrophages using a mouse monoclonal antibody (ED-1) specific for CD68 (1: 100; Abcam, Tokyo, Japan), for type I and type III collagens using goat polyclonal antibodies specific for type I (1: 200; Southern Biotech, Birmingham, AL, USA) and type III (1: 200; Southern Biotech) collagen, and for endothelial cells using a mouse monoclonal antibody specific for rat endothelial cell antigen-1 (RECA-1) (1: 100; Abcam). Labeled proteins were visualized using polymeric horseradish peroxidase (HRP)-conjugated secondary antibodies (ImmPRESS TM polymer detection kit; Vector Laboratories, Burlingame, CA, USA). Peroxidase activity was detected via the diaminobenzidine reaction (Liquid DAB+; DAKO Japan, Tokyo, Japan), and sections were counterstained with hematoxylin.
For quantification, images from 10 nonoverlapping fields throughout the cortical and outer medullary regions were captured at ×100 magnification. The extent of macrophage and interstitial myofibroblast infiltration in the cortical and outer medullary interstitia were automatically measured using an image analyzer (WinRoof v6.4, Mitani, Tokyo, Japan). Briefly, the areas positively stained for α-SMA, CD68, and RECA-1 were independently measured and expressed as ratios relative to the areas of the entire cortical and outer medullary regions. The same method was used to measure the expression levels of both type I and type III collagen. Furthermore, to evaluate the expansion of mesangial matrix, type IV collagen was labeled using a rabbit polyclonal antibody (1: 500; Cedarlane Laboratories, ON, Canada) in sections that were fixed in formalin [26] . Thirty glomeruli in the cortical area were analyzed. Briefly, areas positively stained for type IV collagen in each glomerulus as well as the size of each glomerulus were measured with WinRoof image analyzer, and then expressed as ratios relative to the total glomerular areas.
Real-Time Quantitative Reverse Transcription Polymerase Chain Reaction
Total RNA was extracted from the kidney tissues using a RNeasy midi kit (Qiagen, Valencia, CA, USA) according to the manufacturer's instructions, and a 0.5-μg aliquot was reverse-transcribed. TaqMan real-time polymerase chain reaction (PCR) with StepOne-Plus TM real-time PCR system (Applied Biosystems, Waltham, MA, USA) was used to measure the mRNA levels of monocyte chemoattractant protein (Mcp-1), transforming growth factor-β (Tgf-β), CD31, Hif-1α, vascular endothelial growth factor (Vegf), and 18S ribosomal RNA (18s). The expression levels of all mRNAs were normalized to the levels of 18s in all samples.
Renal Protein Expression of Vascular Endothelial Growth Factor
Renal vascular endothelial growth factor (VEGF) protein expression levels were determined using an ELISA kit from R&D Systems (Minneapolis, MN, USA) with protein extracted from frozen kidney tissues, after determining protein concentrations as described previously [27] .
Western Blotting
Proteins were extracted from frozen kidney tissues, and protein concentrations were measured as described previously [28] . Next, 60 µg of extracts were separated by SDS-PAGE using NuPAGE 4-12% Bis-Tris gels and the XCell SureLock Mini-Cell system (Thermo Fisher Scientific, Rockford, IL, USA). The separated proteins were transferred to PVD membranes using the iBlot TM dry blotting system (Thermo Fisher Scientific), and the membranes were blocked in Blocking One solution (Nacalai Tesque, Kyoto, Japan). Primary antibodies against HIF-1α (rabbit monoclonal, #14179, 1: 1,000; Cell Signaling Technology, Danvers, MA, USA), endothelial nitric oxide synthase (eNOS, rabbit polyclonal, #9572, 1: 1,000; Cell Signaling Technology), and phospho-eNOS (rabbit polyclonal, #9571, 1: 1,000; Cell Signaling Technology) diluted in Can Get Signal Solution I (TOYOBO, Osaka, Japan) were incubated overnight at 4 ° C. After washing, the membranes were incubated with an HRP-conjugated anti-rabbit antibody (Santa Cruz Biotechnology, Dallas, TX, USA) diluted at 1: 2,000 for phospho-eNOS and eNOS or 1: 4,000 for HIF-1α in Blocking One solution for 1 h at room temperature. Subsequently, chemiluminescence was detected using ECL Prime Western blotting detection reagent (GE Healthcare, Little Chalfont, UK) with a CCD camera system (Ez-Capture II, ATTO, Tokyo, Japan). A rabbit monoclonal antibody to α-tubulin (1: 4,000; Abcam) was also used to detect α-tubulin on the same membranes that were incubated with HIF-1α, eNOS, and phospho-eNOS, after treatment with a stripping buffer (WAKO); the expression levels of the 3 proteins were normalized to that of α-tubulin. The expression levels of all proteins were quantified using ImageJ software (National Institutes of Health, Frederick, MD, USA).
Statistical Analysis
All values were expressed as means ± standard error of the mean (SEM). A p value < 0.05 was considered to indicate statistical significance. Differences between SD and SDT rats were analyzed by the Steel test. The 2 groups were compared using the Mann-Whitney U test. Spearman's rank correlation coefficient was used to evaluate nonparametric data and assess correlations between 2 parameters. All statistical analyses were performed using JMP ® software v13.0.0 (SAS Institute, Cary, NC, USA).
Results
Changes in Body Weight, Blood Glucose, and SBP
In both groups, the body weight, blood glucose, and SBP values were measured every 4 weeks in rats aged between 8 and 24 weeks (Table 1 ). Body weight was significantly higher in the 12-, 16-, 20-, and 24-week-old rats than in the 8-week-old rats in both groups. Additionally, the body weights of the 8-, 12-, and 16-week-old SDT fatty rats were significantly higher than those of the age-matched SD rats. Similarly, the blood glucose levels of the SDT fatty rats were significantly higher than those of the SD rats throughout the observation period. Although the SBP levels did not change over time in the SD rats, they were significantly higher at 12 weeks than at 8 weeks in the SDT fatty rats. Furthermore, they were significantly higher in the SDT fatty rats than in the SD rats at both 12 and 20 weeks.
Comparison of Kidney Function and Total Cholesterol
The SDT fatty rats exhibited significant increases in the levels of serum creatinine and urea nitrogen compared to the SD rats at 24 weeks of age (Table 2) , but there was no significant difference in the serum cystatin C levels between the 2 groups. Conversely, the serum total cholesterol level in the SDT fatty rats was significantly higher than in the SD rats at 24 weeks of age.
Comparison of Urinary Glucose, L-FABP, and Albumin Levels
The mean scores for urinary glucose were 4 and 0 in the SDT fatty rats and SD rats, respectively, at 24 weeks of age. The levels of both urinary L-FABP and albumin were significantly higher in the SDT fatty rats than in the SD rats at 24 weeks of age (Fig. 1A, B ).
Increased Inflammatory Response and Profibrotic Activity in the SDT Fatty Rat Model of DKD
The mRNA levels of Mcp-1, Tgf-β, and CD31 were measured to evaluate the inflammatory response, profibrotic activity, and presence of endothelial cells, respectively. The Mcp-1 (Fig. 1C) and Tgf-β (Fig. 1D ) levels were significantly higher in the SDT fatty rats than in the SD rats, whereas the level of CD31 was comparable between the SDT fatty rats and SD rats (Fig. 1E) . 
IHC Analysis of the Kidneys
To evaluate the degree of renal interstitial inflammation, we utilized the macrophage marker CD68 in IHC analysis. The macrophages were detected in the interstitium of the SDT fatty rats ( Fig. 2A) , and the degree of macrophage infiltration was significantly greater than in the SD rats (Fig. 2B) . IHC analyses were also performed to evaluate tubulointerstitial fibrosis based on the expression levels of α-SMA and type I and type III collagens. In the SDT fatty rats, α-SMApositive areas were observed in the tubules and the interstitium (Fig. 2C) ; the extent of α-SMA positivity was significantly greater in the SDT fatty rats than in the SD rats ( Fig. 2D ). Further analysis of the expression levels for type I (Fig. 2E ) and type III (Fig. 2G ) collagen in the interstitium revealed that the extent of positivity for both type I (Fig. 2F ) and type III (Fig. 2H ) collagen was significantly greater in the SDT fatty rats than in the SD rats.
Assessment of the number of endothelial cells in the peritubular capillaries by IHC analysis for RECA-1 revealed that the extent of RECA-1 positivity was comparable between the SDT fatty rats and the SD rats ( Fig. 2I, J) .
Evaluation of Glomerular Sclerosis
Focal glomerular sclerosis was observed in the PAS-stained kidney tissues of the SDT fatty rats (Fig. 3A) , and the score for glomerular sclerosis was significantly greater than in the SD rats ( Fig. 3B ). Additionally, type IV collagen was immunolocalized to the mesangial areas in the glomeruli (Fig. 3C ). Furthermore, the glomerular area that was positively stained for type IV collagen was significantly increased in the SDT fatty rats compared to the SD rats ( Fig. 3D ).
Correlation between Urinary L-FABP Level and Histological Changes
The urinary L-FABP levels correlated significantly with both the degree of macrophage infiltration determined by the CD68-positive areas (Fig. 4A) , and tubulointerstitial fibrosis determined by the areas positive for α-SMA ( Fig. 4B ) and type I ( Fig. 4C ) and type III (Fig. 4D ) collagen.
Analysis of HIF-1α Expression and Correlation of HIF-1α Protein Expression with Urinary L-FABP Levels and Histological Changes
The measurement of HIF-1α expression levels in the kidneys to assess renal hypoxia revealed that both the mRNA (Fig. 5A ) and protein (Fig. 5B ) levels were significantly higher in the SDT fatty rats than in the SD rats.
The protein expression levels of HIF-1α correlated significantly with the urinary L-FABP levels (Fig. 6A) , macrophage infiltration determined by the CD68-positive areas (Fig. 6B) , and tubulointerstitial fibrosis determined by the areas positive for α-SMA ( Fig. 6C ) and type I (Fig. 6D) . However, no similar correlation was observed between the protein expression levels of HIF-1α and type III collagen (Fig. 6E ).
Evaluation of Renal Blood Flow Using DCS and Correlation of Renal BFI with Urinary L-FABP Levels, Histological Changes, and Renal HIF-1α Protein Expression
The analysis of the kidneys with DCS revealed that the microvascular BFI in the SDT fatty rats was significantly lower than in the SD rats (Fig. 7 ). expression levels of eNOS were significantly higher in the kidneys of the SDT fatty rats than in the SD rats (Fig. 9A, B) , and that the phosphorylation (Fig. 9A , C) levels of eNOS were comparable between the SDT fatty rats and SD rats. Phosphorylated protein amount of eNOS was therefore considered to be higher in the kidneys of the SDT fatty rats than in the SD rats.
Analysis of VEGF Expression
The angiogenic activity in response to renal hypoxia was assessed by the measurement of VEGF expression levels in the kidneys, which revealed that both the mRNA (Fig. 9D ) and protein ( Fig. 9E ) levels of VEGF were comparable between the SDT fatty rats and SD rats.
Discussion
Utilizing SDT fatty rats as a novel animal model of type 2 diabetes with obesity, we revealed that, compared to the control SD rats, the renal HIF-1α levels were elevated and renal BFI was reduced in the SDT fatty rats, accompanied by renal tissue damage including glomerulosclerosis, interstitial inflammation, and fibrosis. The study also revealed a comparable frequency of endothelial cells in the peritubular capillaries, eNOS phosphorylation, and VEGF expression between the SDT fatty rats and the SD rats. These results suggest that the kidneys in the SDT fatty rats were under hypoxic conditions. In addition, the urinary L-FABP levels, which were significantly higher in the SDT fatty rats than in the SD rats, were positively correlated with the degree of renal HIF-1α expression and negatively correlated with the renal BFI, suggesting that urinary L-FABP might reflect the degree of renal hypoxia in DKD. Along with previous evidence, the observed correlation of the renal expression of HIF-1α and renal BFI with interstitial inflammation and interstitial fibrosis (Fig. 6, 8 ) provides support for the notion that renal hypoxia is a crucial aggravating factor for tubulointerstitial damage in DKD [7, 8] . These results further suggest that, by detecting renal hypoxia, urinary L-FABP might be useful for monitoring DKD in clinical practice. Although urinary L-FABP was reported to be associated with renal microvascular blood flow in renal transplantation [19] , our study is the first to report its potential as a renal hypoxic marker in DKD in type 2 diabetes. SDT fatty rats, utilized in numerous diabetic animal models, exhibit various metabolic complications frequently observed in patients with type 2 diabetes, such as obesity, hyperlipidemia, and hypertension [20] . In patients with type 2 diabetes, various metabolic abnormalities have an impact on the kidneys, in addition to hyperglycemia, and numerous factors contribute to the onset and/or progression of kidney disease. The renal pathophysiology in SDT fatty rats may mimic the DKD observed in type 2 diabetic patients with numerous metabolic complications. Both macroalbuminuria and mild renal dysfunction were observed in the 24-week-old SDT fatty rats. Our results may thus reflect the relationship between renal hypoxia and urinary L-FABP levels in DKD with macroalbuminuria observed in humans.
Two mechanisms underlie the induction of renal hypoxia in type 2 diabetes: elevated renal oxygen consumption and changes in renal hemodynamics. One study reported a > 40% increase in oxygen consumption in the renal tubules of diabetic rats compared to nondiabetic rats [29] . The increase in renal oxygen consumption is attributed to increased renal tubular reabsorption of massive levels of glucose filtered in the glomeruli as a result of hyperglycemia, increased electrolyte levels after glomerular hyperfiltration [7, 30] , and increased oxidative stress in diabetes [31] . Conversely, renal hemodynamics are altered by both glomerular and tubular damage in addition to a decrease in whole renal blood flow due to arteriosclerosis. Glomerular damage, which is induced by hyperglycemia, obesity, hypertension, and arteriolosclerosis, leads to a decrease in postglomerular blood flow, resulting in tubular hypoxia. Furthermore, a direct insult to the tubular cells by hyperglycemia leads to the production of inflammatory cytokines which provoke peritubular capillary damage [32, 33] , resulting in the induction of tubular hypoxia [34] . In this study, there was an increase in urinary glucose excretion in the SDT fatty rats. Furthermore, while we failed to observe a decrease in endothelial cell numbers or eNOS activation, we found an increase in renal HIF-1α expression, a reduction in renal BFI, and mild glomerulosclerosis in the SDT fatty rats. Therefore, we attribute the renal hypoxia observed in 24-week-old SDT fatty rats to elevated renal oxygen consumption that was due to the increased renal tubular absorption of glucose as well as a reduction in glomerular and postglomerular blood flow as a result of glomerulosclerosis.
Adaptation of the kidneys to renal hypoxia occurs via an increase in HIF-1α expression, which leads to the upregulation of VEGF that accelerates angiogenesis [35] [36] [37] . Our results did not reveal an increase in the renal expression of VEGF in the SDT fatty rats compared to the SD rats, but the renal HIF-1α expression was significantly increased in the SDT fatty rats.
It has been reported that hyperglycemia suppresses angiogenesis despite the increased gene expression of VEGF receptors in cocultures of human proximal tubular cells and endothelial cells [36] . Furthermore, hyperglycemia during hypoxia was found to inhibit the upregulation of VEGF expression due to oxidative stress in rat proximal tubular cells [38] . Our results lend further support to these previous in vitro findings.
We used DCS to measure renal microvascular blood flow. The currently adopted interval between photon-emitter and detector probes is 4 mm, with which the microvascular blood flow of the corticomedullary junction approximately 2 mm below the renal surface can be detected. The corticomedullary junction is reported to consume approximately half the oxygen of the whole kidney due to the wide distribution of the electrolytic pumps using ATP [39] ; this area is therefore particularly vulnerable to hypoxia. Conversely, the corticomedullary junction is susceptible to hypoxia in kidney disease because the blood flow in this area is solely dependent on the postglomerular flow of the juxtamedullary glomeruli. Specifically, hypertension, a major and frequent complication of type 2 diabetes [40] , initially induces vascular damage in the juxtamedullary glomeruli, and this leads to hypoxia in the corticomedullary and medullary regions by impairing renal circulation [41] . Therefore, the DCS method for measuring microvascular blood flow in the corticomedullary region utilized here was suitable for detecting renal hypoxia.
The results of this study may have been limited by several factors. First, the presence of anemia was not evaluated. There is a possibility that renal anemia occurs in SDT fatty rats with mild renal function. As the DCS method detects the movement of red blood cells, changes in the number of these cells might affect BFI measurement. The potential confounding effect of anemia should be elucidated in future studies. Second, the correlation between renal hypoxia and DKD progression was not investigated. The progression of DKD was mild, even in the SDT fatty rats with macroalbuminuria [42, 43] ; therefore, older SDT fatty rats, such as 60-week-old animals, should be evaluated for the correlation of renal hypoxia with the progression to advanced DKD [44] . One of the SDT fatty rats died at 23 weeks of age and the presumed cause was malnutrition due to the long-term impairment of glucose utilization, although necropsy was not performed. So no long-term assessment was conducted. Third, because of the small sample size in the basic research, we did not determine the most suitable marker to accurately reflect the degree of renal hypoxia. More clinical research is needed to reveal the point. Finally, we did not investigate changes in urinary L-FABP levels in response to interventions that ameliorate renal hypoxia. A recent study demonstrated that habitual exercise leads to a reduction in urinary L-FABP levels via a decrease in renovascular resistance and an improvement of renal microcirculation in healthy middle-aged and older adults [45] . Another clinical study reported that urinary L-FABP decreased along with the improvement of renal disease due to various treatments [46] . Urinary L-FABP may thus respond to the elimination of renal hypoxia.
In conclusion, we revealed that urinary L-FABP levels reflect the degree of renal hypoxia, as evaluated by renal HIF-1α expression and BFI measured with DCS in DKD using a type 2 diabetic animal model. Although further investigation is necessary, these findings suggest that urinary L-FABP might be useful as a renal hypoxic marker to monitor DKD in patients with type 2 diabetes in clinical practice because renal hypoxia is an aggravating factor for the progression of DKD.
